• Explore /
  • Poster
  • / Phase II study of RCHOP with pegylated liposomal doxorubicin (DRCOP) for patients older than age 60 with untreated diffuse large B-cell lymphoma (DLBCL).

Phase II study of RCHOP with pegylated liposomal doxorubicin (DRCOP) for patients older than age 60 with untreated diffuse large B-cell lymphoma (DLBCL).

Abstract Poster

Authors

Maria Rodriguez

M. A. Rodriguez

University of Texas M. D. Anderson Cancer Center, Houston, TX

M. A. Rodriguez , J. Durand , A. B. Astrow , M. J. Bury , M. A. Fanale , F. B. Hagemeister Jr., X. Huang , P. McLaughlin , S. S. Neelapu , B. Pro , L. W. Kwak , L. Fayad , J. E. Romaguera , A. Younes , M. Fisch

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Lymphoma

Clinical Trial Registration Number

NCT00101010

Citation

J Clin Oncol 29: 2011 (suppl; abstr 8053)

Abstract #

8053

Poster Bd #

46A

Abstract Disclosures

Similar Posters

First Author: David Lavie

First Author: Bei Hu

First Author: Joaquin Herrero

First Author: J. Leonard